Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate.These agents work by binding to phosphate in the GI tract, thereby making it unavailable to the body for absorption. Hence, these drugs are usually taken with meals to bind any phosphate that may be present in the ingested food.

Market Analysis and Insights: Global and Japan Phosphate Binders Market
This report focuses on global and Japan Phosphate Binders market.
In 2020, the global Phosphate Binders market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Phosphate Binders market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Phosphate Binders Scope and Market Size
Phosphate Binders market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Phosphate Binders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Phosphate Binders market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Calcium Carbonate
Calcium Acetate
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Opko Health
Akebia Therapeutics
Sanofi
Baxter
Shire
Natco
Novartis
Amgen
Torii Pharmaceutical
Meda Pharmaceuticals
AMAG Pharmaceuticals
Vifor Pharma